Emily
Editor, Senior Moderator
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242437/
Mazzatenta C, Piccolo V, Pace G, Romano I, Argenziano G, Bassi A. Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID-19 vaccine: another piece of SARS-CoV-2 skin puzzle?. J Eur Acad Dermatol Venereol. 2021;35(9):e543-e545. doi:10.1111/jdv.17340
Dear Editor,
Vaccination against SARS‐CoV‐2 has spread around the world since December 2020. Herein, we describe three patients, with no history of SARS‐CoV‐2 infection, who developed skin reactions after receiving Pfizer‐BioNTech (New York, NY, USA) COVID‐19 vaccine. The first patient was a 44‐year‐old woman who presented with purpuric lesions on the right and left eyelid, respectively, 21 and 25 days after the second dose of the BNT162b2 mRNA vaccine (Fig. 1c,d). The lesions were circumscribed on the upper eyelid, totally asymptomatic and resolved spontaneously after ten days. The second patient was a 63‐year‐old man who presented similar lesions on the upper eyelid three weeks after the second dose of the vaccine (Fig. 1a,b). The lesions were asymptomatic as well and resolved spontaneously after 15 days. Both patients had complete laboratory evaluation for coagulation disorders that resulted unremarkable.
(Photos at link.)
Mazzatenta C, Piccolo V, Pace G, Romano I, Argenziano G, Bassi A. Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID-19 vaccine: another piece of SARS-CoV-2 skin puzzle?. J Eur Acad Dermatol Venereol. 2021;35(9):e543-e545. doi:10.1111/jdv.17340
Dear Editor,
Vaccination against SARS‐CoV‐2 has spread around the world since December 2020. Herein, we describe three patients, with no history of SARS‐CoV‐2 infection, who developed skin reactions after receiving Pfizer‐BioNTech (New York, NY, USA) COVID‐19 vaccine. The first patient was a 44‐year‐old woman who presented with purpuric lesions on the right and left eyelid, respectively, 21 and 25 days after the second dose of the BNT162b2 mRNA vaccine (Fig. 1c,d). The lesions were circumscribed on the upper eyelid, totally asymptomatic and resolved spontaneously after ten days. The second patient was a 63‐year‐old man who presented similar lesions on the upper eyelid three weeks after the second dose of the vaccine (Fig. 1a,b). The lesions were asymptomatic as well and resolved spontaneously after 15 days. Both patients had complete laboratory evaluation for coagulation disorders that resulted unremarkable.
(Photos at link.)